Table 1. Relationship of NUF2 expression and clinicopathological parameters in PDAC patients (n=128).
P values were determined using a Pearson χ2 test.
NUF2 immunostaining | ||||
---|---|---|---|---|
Characteristic | n | -/+ | ++/+++ | P |
Age | ||||
≤62 years | 65 | 29 | 36 | 0.263 |
>62 years | 63 | 22 | 41 | |
Gender | ||||
Female | 59 | 19 | 40 | 0.103 |
Male | 69 | 32 | 37 | |
Tumour location | ||||
Head | 56 | 20 | 36 | 0.400 |
Body/tail | 72 | 31 | 41 | |
Tumour size | ||||
≤2 cm | 29 | 10 | 19 | 0.445 |
2–4 cm | 57 | 21 | 36 | |
>4 cm | 42 | 20 | 22 | |
Lymph node metastasis | ||||
N0 | 84 | 39 | 45 | 0.036* |
N1 | 44 | 12 | 32 | |
Tumour differentiation | ||||
Well/moderate | 89 | 37 | 52 | 0.546 |
Poor | 39 | 14 | 25 | |
TNM stage | ||||
I/II | 95 | 45 | 50 | 0.003** |
III/IV | 33 | 6 | 27 |